Niki BioSolutions, Inc. (NIKI)
NASDAQ: NIKI · Real-Time Price · USD
1.770
-0.186 (-9.51%)
At close: Oct 30, 2026, 4:00 PM EDT
1.700
-0.070 (-3.95%)
After-hours: Oct 30, 2026, 7:33 PM EDT
Niki BioSolutions Employees
Niki BioSolutions had 1 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Niki BioSolutions the 44,072nd largest employer in the world and 7,268th in the United States.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,247,494
Market Cap
5.20M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1 | 0 | - | 1 | 0 |
| Dec 31, 2024 | 1 | -2 | -66.67% | 1 | 0 |
| Dec 31, 2023 | 3 | -16 | -84.21% | 3 | 0 |
| Dec 31, 2022 | 19 | -7 | -26.92% | 18 | 1 |
| Dec 31, 2021 | 26 | 0 | - | 26 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Longeveron | 38 |
| Cardio Diagnostics Holdings | 17 |
| Processa Pharmaceuticals | 12 |
| Aprea Therapeutics | 8 |
| Alzamend Neuro | 6 |
| XTL Biopharmaceuticals | 5 |
| Acurx Pharmaceuticals | 4 |
NIKI News
- 5 days ago - Niki BioSolutions Announces New York State Approval for Its APOE Genotyping Test Using Dried Blood Spots, Plasma, and Urine - GlobeNewsWire
- 8 days ago - Niki BioSolutions Signs Agreement to Supply APOE Genotyping to Charter Research - GlobeNewsWire
- 15 days ago - Niki BioSolutions' Rett Syndrome Biomarker Program Featured in the International Rett Syndrome Foundation's “Rett Research Tool Belt” Series - GlobeNewsWire
- 17 days ago - Niki BioSolutions Partners with Global Alzheimer's Platform Foundation to Deliver Plasma-Based APOE Genotyping for Bio-Hermes-002 - GlobeNewsWire
- 5 weeks ago - Niki BioSolutions to Participate in the Lytham Partners Fall 2026 Investor Conference - GlobeNewsWire
- 6 weeks ago - Niki BioSolutions Accelerates Its Alzheimer's Disease Testing Pipeline Through Strategic Bioinformatics and Statistical Analysis Partnership with Fios Genomics - GlobeNewsWire
- 7 weeks ago - Niki BioSolutions to Participate in H.C. Wainwright's 28th Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - Niki BioSolutions files $75M mixed securities shelf - TheFly